Fellowship · New York, NY
Sponsored by Icahn School of Medicine at Mount Sinai
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 90 citations · Lauren Weintraub
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 222 citations · John E Levine
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory.
Cancer cell · 2023 · 101 citations · Oren Becher
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.
Nature cancer · 2021 · 146 citations · Stephen Gilheeney
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 98 citations · John E Levine
Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients.
Neuro-oncology · 2022 · 93 citations · Stephen Gilheeney
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD.
Blood · 2024 · 33 citations · John E Levine
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD.
Blood advances · 2023 · 40 citations · John E Levine